entertainment -WSS

entertainment

author：knowledge 2025-09-02 22:07:10 - browse：85155

FogPharma CEO Mathai Mammen Venrock

SAN FRANCISCO — Six months into his tenure as CEO of cancer startup FogPharma, Mathai Mammen is taking the stage at the Westin St. Francis Tuesday for what he’s calling a “big unveil” of how he’s reshaping the biotech. And he’s prepared to go against the grain.

Perhaps the most important thing he’s telling investors at the J.P. Morgan Healthcare Conference is that he plans to eventually pursue a rare Series E round, rather than an IPO or seeking out acquisition offers.

FogPharma last raised money in November 2022, and will need more cash to bring its lead drug past its ongoing Phase 1/2 trial. Most other biotechs in this position are anxiously eyeing the capital markets, hoping that conditions improve and make an IPO more feasible. But Mammen doesn’t see the point, at this stage. “There’s no reason to be a public company. I don’t know why you’d want to be, really,” he told STAT ahead of FogPharma’s presentation.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Use wet bulb globe temperature, not heat index, to protect workers

WSS

Abortion pill case raises question: who can sue the FDA?

Readout Newsletter: Merck, Vertex, and Viking updates

Study says nonprofit hospitals fall short in charity care spending

Food as medicine: Medically tailored meals may get standardized

Scientists boost immune system in aging mice by making it youthful

Alcohol isn't healthy after all. Will new dietary guidelines reflect that?

explore

entertainment

focus

Heart attack and stroke risk calculators need revising

Researchers on aging grapple with how to calculate biological age

Medicare details structure of new drug price negotiation program

Supreme Court mifepristone arguments center on docs' right to sue

FDA approval of Sarepta Duchenne genetic therapy gives me hope

There's no autism epidemic. It's an autism diagnosis epidemic

Sports medicine is finally prioritizing gender equality

Study: Adult vaccinations pay for themselves in societal benefits

Duchenne breakthrough therapy leaves behind pioneering families

Decaf coffee targeted by food safety group under obscure FDA rule

entertainment

Decaf coffee targeted by food safety group under obscure FDA rule

Use wet bulb globe temperature, not heat index, to protect workers

What nurses really want: sufficient staffing for patient care

Elevance, private equity launch primary care company

Google says AlphaFold 3 can map a vast universe of biomolecules

Bird flu outbreak in cows is latest avian flu curveball

entertainment

Wikipedia

focus

hotspot